Models and methods to evaluate transport of drug delivery systems across cellular barriers.
Models and methods to evaluate transport of drug delivery systems across cellular barriers.
复制标题
DOI:
10.3791/50638
复制
发表时间:
2013-10-17
期刊:
影响因子:
--
通讯作者:
Muro S
中科院分区:
文献类型:
--
作者:
Ghaffarian R;Muro S
Many therapeutic applications require safe and efficient transport of drug carriers and their cargoes across cellular barriers in the body. This article describes an adaptation of established methods to evaluate the rate and mechanism of transport of drug nanocarriers (NCs) across cellular barriers, such as the gastrointestinal (GI) epithelium. Sub-micrometer carriers (nanocarriers; NCs) enhance efficacy of drugs by improving solubility, stability, circulation time, targeting, and release. Additionally, traversing cellular barriers in the body is crucial for both oral delivery of therapeutic NCs into the circulation or transport from the blood into tissues, where intervention is needed. NC transport across cellular barriers is achieved by: (i) the paracellular route, via transient disruption of the junctions that interlock adjacent cells, or (ii) the transcellular route, where materials are internalized by endocytosis, transported across the cell body, and secreted at the opposite cell surface (transyctosis). Delivery across cellular barriers can be facilitated by coupling therapeutics or their carriers with targeting agents that bind specifically to cell-surface markers involved in transport. Here, we provide methods to measure the extent and mechanism of NC transport across a model cell barrier, which consists of a monolayer of gastrointestinal (GI) epithelial cells grown on a porous membrane located in a transwell insert. Formation of a permeability barrier is confirmed by measuring transepithelial electrical resistance (TEER), transepithelial transport of a control substance, and immunostaining of tight junctions. As an example, ~200-nm polymer NCs are used, which carry a therapeutic cargo and are coated with an antibody that targets a cell-surface determinant. The antibody or therapeutic cargo is labeled with 125I for radioisotope tracing and labeled NCs are added to the upper chamber over the cell monolayer for varying periods of time. NCs associated to the cells and/or transported to the underlying chamber can be detected. Measurement of free 125I allows subtraction of the degraded fraction. The paracellular route is assessed by determining potential changes caused by NC transport to the barrier parameters described above. Transcellular transport is determined by addressing the effect of modulating endocytosis and transcytosis pathways.
登录
查看更多内容
影响因子:
14
作者:
Simone, Eric A.;Zern, Blaine J.;Chacko, Ann-Marie;Mikitsh, John L.;Blankemeyer, Eric R.;Muro, Silvia;Stan, Radu V.;Muzykantov, Vladimir R.
通讯作者:
Muzykantov, Vladimir R.
DOI:
10.1016/j.ejpb.2008.09.026
发表时间:
2009-03
期刊:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
影响因子:
--
作者:
Torchilin V
通讯作者:
Torchilin V
DOI:
10.1016/j.jconrel.2010.10.031
发表时间:
2011-02-10
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Hsu J;Serrano D;Bhowmick T;Kumar K;Shen Y;Kuo YC;Garnacho C;Muro S
通讯作者:
Muro S
影响因子:
14.8
作者:
Hubatsch, Ina;Ragnarsson, Eva G. E.;Artursson, Per
通讯作者:
Artursson, Per
DOI:
10.1146/annurev-anchem-062011-143002
发表时间:
2012
期刊:
Annual review of analytical chemistry (Palo Alto, Calif.)
影响因子:
--
作者:
Kuhnline Sloan CD;Nandi P;Linz TH;Aldrich JV;Audus KL;Lunte SM
通讯作者:
Lunte SM